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2DO STOCK MARKETS VALUE INNOVATION?
A META-ANALYSIS
ABSTRACT
We analyze whether stock markets value innovation by performing a meta-analysis of the empirical
literature linking R&D investments and firms’ market value. While there is an increasing interest in
the attention paid by financial markets to firm level innovation activities, the theoretical debate and
the empirical results presented by a growing number of studies performed within different
disciplinary domains still oscillate between markets myopia and markets efficiency. We contribute
to resolve this indecision applying Hunter and Schmidt (1990) correction procedures on existing
studies estimating the impact of different corporate assets on the market value of the firm. After
correcting for random sources of variations and possible problems with the reliability of the
independent and the dependent variables, we show that the R&D-market value relationship is
consistently positive and that the market values one currency unit invested in R&D activities as
much or more than one currency unity invested in tangible assets. Moreover, we use a fully factorial
regression model to assess the magnitude of the reported coefficients against a set of sample
specific and design specific variables. Our results show that, when other intangible assets are
considered, the market valuation of firms’ R&D investments generally lowers. Moreover, whereas
adding industry-level controls seems to better specify the relationship between R&D investment and
market value, firm-level variables do not substantially affect the results. Implications for research
and practice are presented and discussed.
3INTRODUCTION
Economics and strategy literature has extensively recognized that innovation represents the engine
of economic growth for the firm and the economic system in general. In spite of such attention to
the role technological innovation, however, we are still lacking adequate schemes for its
measurement and valuation (Lev, 2001). A main problem is that expected results from R&D
investments or other innovation activities are subject to a very high degree of uncertainty
(Mansfield et al., 1977). As a consequence, it is often hard to predict how investments in innovation
will impact on firm value as determined by stock markets (Oriani and Sobrero, 2002). Clearly, this
shortcoming is relevant to critical decisions of managers seeking shareholder wealth maximization,
such as resource allocation to corporate innovative activities or the recourse to capital markets for
R&D financing.
Indeed, some interesting indications to understand how stock markets evaluate firms’
innovation activities can be drawn from a broad stream of empirical literature in the fields of
industrial organization and financial economics that has investigated the relationship between
several firm-level measures of technological innovation and stock market indicators. Different
approaches have been adopted. Some studies have analyzed the relationship between the stock of
R&D investments or patents and a firm’s market value at a given time (Griliches 1981; Jaffe 1986;
Hall 1993a, 1993b, among others), whereas others have observed the long-run stock returns
associated with R&D-based measures (Pakes, 1985; Lev and Sougiannis, 1996; Chan et al. 2001,
among others) or short-term market value adjustments following corporate announcements on R&D
activity (Chan et al. 1990; Woolridge and Snow 1990, among others).
However, the interpretation of these studies for the strategic management of innovation is
complicated by several difficulties. First, the concept of innovation itself is very broad and hard to
4precisely define from an empirical point of view (Griliches, 1995). Consequently, the
abovementioned studies have adopted different variables to measure this construct. Second, it is not
ascertained if the market valuation fully reflects future benefits from innovation. In this respect,
some authors have found evidence for a systematic underestimation of firms’ R&D investments by
the stock market (Lev and Sougiannis 1996, 1999; Chan et al., 2001). Third, the application of
different  methodologies and research designs to the problem of the market value of innovation has
led to results that not always coincide. In fact, even though all analyses generally show a positive
valuation of innovation, this has proved to be very erratic. In particular, several studies have shown
how the market valuation of R&D investments is volatile over time (Lustgarten and Thomadakis,
1987; Hall, 1993a, 1993b) and across industries (Jaffe, 1986; Cockburn and Griliches, 1988) or
countries (Hall and Oriani, 2004).
Considering the amount of available empirical evidence, the practical and theoretical
importance of the subject, and the evolution of financial markets all over the world, a formal
cumulative analysis of the results can offer several insights. First, it can give an informative
assessment of the level of agreement or not among the studies conducted so far. Second, it can
partial out from the various estimates the effect, if any, of several measurement problems usually
discussed. Third, it can test whether the variance among the results is random or due to some
moderating effect. Fourth, it can assess whether and how different choices related to the research
design, such as sample characteristics or the inclusion of control variables accounting for alternative
hypotheses, affect the empirical estimate of the market value of innovation. Finally, it can offer
specific and stimulating insights not only to scholars interested in continuing this line of research,
but also to researchers in other fields of study, by suggesting unexplored paths and raising possible
inconsistencies, while avoiding inefficient replications on findings already robust and systematic.
5To move in this direction, we conducted a meta-analysis of the empirical literature linking
R&D investments and firm market value. We assessed the magnitude of the reported coefficients
against three broad classes of potential moderating factors: the reliability of the independent and the
dependent variables; the inclusion of firm- and industry-level control variables; sample
characteristics. Applying Hunter and Schmidt (1990) correction procedures on all published studies
using empirical models to estimate the impact of different corporate assets on the market value of
the firm we show that the relationship between R&D-based measures of innovation and firm value
is consistently positive. Significant differences in the size of the effect emerge, however, depending
on the different variables considered in the meta-analysis.  
The paper is organized as follows. In the next section we will discuss the main theoretical
and empirical issues of the models reviewed in the meta-analysis. In the third section the meta-
analytic procedure is described, with specific attention to the selection of the studies, the data
coding and the statistical tests. In the fourth section the results of the meta-analysis are presented,
while in the final section the main implications for future research are discussed.
THEORETICAL BACKGROUND
The study of the relationship between innovation and firm market value is characterized by some
specific problems related to the research designs adopted so far. Such problems are strictly
connected with the resolution of wider theoretical issues. The use of market-based measures of
performance clearly requires some assumptions on the way financial markets work. In particular, it
builds on the statement of stock market informational efficiency, implying that security prices fully
reflect all available information (Fama, 1970). The assumption of market efficiency has
several important implications for our analysis. First, the market capitalization of the firm can be
6considered a reasonable proxy of its value. Second, it should change if and only if the stock market
receives new general or firm-specific information that modifies investors’ expectations about the
cash flows form current and future assets (Pakes, 1985; Woolridge and Snow, 1990).
In this section we start by presenting the different classes of models used by empirical
studies to test these theoretical assumptions, focusing in particular on the subset whose evidence
will be cumulated in the empirical section. This is represented by the studies that analyze the
relationship between different measures of technological innovation and firm market value at a
given time. We then discuss the theoretical reasoning behind alternative measurement choices of
technological innovation and the consequences for our meta-analysis.
Models
A large group of studies has focused on the analysis of the relationship between different measures
of innovation and firm market value at a given moment in time. These studies were particularly
appropriate for a meta-analysis because of the large amount of empirical evidences available and
the high comparability of the results obtained. Therefore, this is the stream of literature we decided
to concentrate on.1
These studies implicitly or explicitly assume that the firm is evaluated by the stock market as a
bundle of tangible and intangible assets (Griliches, 1981). In this perspective, firms’ innovation
activities create a stock of technological assets that should be consistently evaluated by the stock
market. In equilibrium, the market valuation of any asset results from the interaction between firms’
                                                 
1 Other alternative research designs have been adopted in literature. A first group has examined the relationship between
R&D investments and the contemporaneous or subsequent stock returns, trying to verify whether the stock market
correctly evaluates corporate innovation activities (Lev and Sougiannis 1996, 1999; Chan et al., 2001). A second group
is based on the event study methodology relating corporate announcements on R&D programs with the stock returns in
the days preceding or following the announcement (e.g. Chan et al., 1990; Woolridge and Snow, 1990). However, both
the groups present a lower number of studies than the one we selected. Moreover, the studies of these groups are
scarcely comparable because of the differences in the empirical methods and the measures of innovation adopted.
7demand for investment and the market supply of capital for that specific asset (Hall, 1993b). It is
then possible to represent the market value V of firm i at time t as a function of it assets:
Vit = V (Ait, Kit, ?Iit) [1]
where Ait is the book value of tangible assets, Kit is the replacement value of a firm’s technological
assets and ?Iit is a set of control variables, including the replacement value of the other intangible
assets.
If single assets are purely additive, it is possible to express the market value of a firm as a
multiple of its assets. Two main functional forms have been adopted by the studies examined.
Those following the seminal contribution of Griliches (1981) have modeled the relationship as
follows:
Vit = b (Ait + ? Kit + ??Iit ) [2]
where b is the market valuation coefficient of a firm’s total assets reflecting its differential risk and
monopoly position, which in equilibrium should be equal to one, ? is the relative shadow value of
technological to tangible assets, and the product b*? measures the total effect of the technological
assets on firm market value (absolute shadow value). The expression [2] is the base of the model
known in literature as hedonic model. Dividing both the members of [2] by A it and taking the
natural logs, we obtain the following expression:
2
log(Vit/Ait) = logb + log(1 + ? Kit/Ait + ?? Iit/Ait [3]
                                                 
2 Some studies do not subtract Ait, obtaining a slight different estimation model. Also in this case, however, the aim of
the estimation is the determination of ?, which is the differential valuation of Kit relative to Ait.
8The ratio Vit/Ait can be considered a proxy of Tobin’s q, which is the ratio of the market
value of a firm’s assets to their replacement cost.3 The estimation of [3] allows us to assess the
average effect of a currency unit invested in technological assets on the market value of the firm.
Hall and Kim (2000), Hall et al. (2000), Bloom and Van Reenen (2002) estimate equation [3]
through Non-Linear Least Squares. Other authors applying the same model use the approximation
log(1+x) ? x obtain a linear equation estimated through Ordinary Least Squares (e.g., Griliches,
1981; Jaffe, 1986; Cockburn and Griliches, 1988; Hall, 1993b). The recent study of Hall and Oriani
(2004) estimate both functional forms without finding substantial differences between the results
reported.
A second additive function that has been adopted is based on the work of Hirschey (1982)
and can be expressed as follows:
?+++= itititit IKAV ???? [4]
Dividing both the terms of [4] by Ait, we have the following general functional form in which the
dependent variable is again a proxy of Tobin’s q (Chauvin and Hirschey, 1993):
Vit/Ait = ? 1/Ait + ? + ? Kit/Ait + ?? Iit/Ai [5]
In this case, the absolute shadow value of the technological assets is measured by the
coefficient ?, whereas in the models based on expression [2] it is represented by the product b*?.
Therefore, in order to compare the results of the two functional forms we will assume b equal to 1.
This is a theoretical assumption of the models described and is normally confirmed by empirical
                                                 
3 Tobin’s q has often been used by studies in industrial organization as a performance measure because of its attractive
theoretical properties: it implicitly uses the correct cash flow risk-adjusted discounted rate, imputes equilibrium returns
9results (Hall, 2000). It is also worth noticing that in equilibrium, if a firm is investing optimally in
all its assets, all the coefficients of both tangible and intangible assets should be equal to 1.
R&D-based measures of technological innovation
The concept of innovation is very broad and difficult to define from an empirical point of view
(Griliches, 1995). Nevertheless, if the definition of comprehensive measures can be too
presumptuous, it is possible to assess the contribution of identified investments in advancing the
state of knowledge in given areas. In particular, previous studies have referred to a large extent to
R&D activity, which is one of the main sources of technological innovation. In this perspective,
R&D investments add value if they are able to generate an intangible asset, that is a stock of
technological assets (Griliches, 1981). Then, an R&D-based measure of firm’s technological assets
should be a stock measure. Accordingly, this has been often computed as the capitalization of
present and past R&D expenditures. In particular, the following expression has been generally
adopted (see Griliches and Mairesse, 1984):
Kt = (1 - ?) Kt-1 + Rt [6]
where Kt is the R&D capital at time t, Rt is the annual R&D expenditure at time t and ? is the
depreciation rate of the R&D capital from year t-1 to year t. The use of expression [6] to capitalize
R&D investments is needed because the accounting principles in all the countries normally require
R&D costs to be written-off to expense when incurred because of the lack of a clear link with
subsequent earnings (see Lev and Sougiannis, 1996; Zhao, 2002). The use of a depreciation rate is
justified by the decay of knowledge over time and the loss of economic value due to advances in
                                                                                                                                                                   
and minimizes distortions due to tax laws and accounting standards (Lindenberg and Ross, 1981; Montgomery and
Wernerfelt, 1988).
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technology. Nearly all the studies analyzed in this paper use a constant annual 15% depreciation
rate (Jaffe 1986; Cockburn and Griliches, 1988; Hall, 1993a, 1993b).
4
Alternatively, some studies have used annual R&D investments instead of R&D capital (e.g.
Cockburn and Griliches 1988; Hall 1993a; Hall and Vopel 1996), because of the persistence of
R&D investments at the firm level over time empirically demonstrated by previous research (e.g.
Hall et al., 1986). Clearly, the coefficients of the studies adopting R&D capital and R&D
investments as alternatives proxies of the stock of technological assets are not directly comparable
because of the different scale of the independent variable. For this reason, in the meta-analysis we
will treat them as separate groups.
It is anyway worth noticing that the studies using R&D capital are more intuitively
interpretable. Since R&D capital is a stock measure consistent with the market value, the coefficient
? has a very clear meaning. It is the market value of one currency unit invested in R&D activities by
the firm. Therefore, if the coefficient ? is greater than 1, it means that investing in R&D enhances
the firm market value more than proportionally. Moreover, given the functions [2] and [4] and
assuming b=1, a value of ? greater than 1 signals that R&D investments are evaluated more than
tangible assets by the stock market. Clearly, the contrary holds when ? is lower than 1. This
interpretation is not valid, instead, for the studies using the R&D investment proxy.
Finally, it is worth noticing that the use of R&D-based measures does not definitively
resolve the questions related to the measurement of technological assets. Some problems still
persist. First, the quality of corporate financial reporting on R&D activity and intangibles is often
inadequate to economic analysis purposes (Lev, 2001). Second, national accounting laws often do
                                                 
4 Other studies adopting a different approach that is not reviewed in this paper use an estimation procedure determining
industry- and time-specific economic depreciation rates (Lev and Sougiannis, 1996, 1999). More precisely, the authors
run a regression model in which the dependent variable is the annual operating income and the independent variables
are the lagged values of total assets, advertising expenditures and a vector of the past R&D investments.
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not require the quantitative the annual R&D expenditures.
5
 Finally, R&D investments are a not an
output, but an input measure of the innovation process. A minority of studies has used patent-based
measures either alternatively to R&D-based measures (e.g. Hall et al., 2000; Bloom and Van
Reenen, 2002) or along with them in the same regression (e.g. Jaffe, 1986) to overcome these
problems. Since patent-based variables are not comparable with R&D-based one, because they are
measured on a different scale, we were forced to exclude from the meta-analysis those few studies
adopting only the former. Instead, for those studies using R&D- and patent-based variables jointly
in the same regression, we controlled for the potential effect of the inclusion of both measures on
the coefficient of R&D capital or R&D investments.
EMPIRICAL ANALYSIS
Sample
To review the empirical results on the relationship between R&D investments and market value of
the firm we proceeded as follows. First, we identified ProQuest and Econlit as the two most
important online literature databases for economics and management related subjects, containing
both published works and working paper series. ProQuest provides global access to one of the
largest online content repositories, including more than a million dissertations and about 4,000
newspapers and periodicals. EconLit is the American Economic Association's electronic
bibliography of economics literature, containing, in addition to published works, working papers
and dissertations in economics. As a complementary source and as a way to check for the
completeness of our extraction, we also used Google Scholar, a special release of the homonymous
                                                 
5 For example, in the European Union, the United Kingdom is one of the few countries where quantitative disclosure of
R&D investments is compulsory, while in France, Germany and Italy there exists only an obligation concerning R&D
qualitative information (KPMG, 1995; Belcher, 1996).
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popular research engine specifically focused on academic contents. We performed a query in each
database with the string “market value” or “firm market value”, our dependent variables, always
appearing alternatively in logic conjunction (operator AND) with “R&D”, “intangible asset”,
“hedonic model” and “Tobin’s q”. Proquest and Econlit returned 236 and 76 papers, respectively,
while Google Scholar returned 1122 links.
We then conducted a first review of the identified papers to consider their usefulness for the
meta-analysis and eliminate duplicates. In particular, we decided to retain those studies which, in
order to estimate firm market value used either one of the functional forms [2] or [4] and, among
the independent variables, included R&D investments or R&D capital. This second constraint was
required because, as specified above, an R&D-based measure of innovation-related intangibles is
not necessarily present in the models described in the previous section. Some authors, for example,
focus only on patents to observe their impact on firm’s market value without taking into account a
specific measurement of R&D. After applying the above set of restrictions, 40 studies remained.
Finally, as a third step, we refined our retention criteria to both ensure the results
comparability across studies and control for some substantial and computational limitations of
meta-analytic studies (Hedges and Olkin, 1985; Rosenthal, 1991). This led to the complete
exclusion of all the papers that neither specified the functional form, nor presented detailed results.
In addition, we did not select those studies using rough proxies for critical dimensions, such as
tangible assets or market value.
Moreover, within the retained studies, we excluded all the regressions including both R&D
investments and R&D capital, because of the multi-collinearity problems associated with the
estimates using this approach. Finally, within each study, we accorded preference to regressions
based on OLS estimation method, which is the most commonly adopted. On the contrary, only a
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relatively limited number of studies employ NLLS (Non Linear Least Square) method solely. While
we took into account results derived from this last method, we deliberately rejected those obtained
through panel data estimators (both fixed and random effects), since their inclusion would have
jeopardized results comparability. At the end of this process we retrieved a total of 28 studies and
48 individual regressions for our meta-analysis. Among these studies, 14 were already published in
refereed journals, 3 were conference papers, and 10 were still under working paper format, albeit
released by primary level research institutions. Fourteen studies (26 regressions) used R&D
Investments and fourteen studies (22 regressions) R&D Capital.
For each study, we then recorded the slope coefficient ? in the regression equations.
However, a standard procedure in economic research is to present and estimate different functional
forms associated with the model developed and compare the emerging results. When multiple
regressions are present in a single paper, the non-trivial problem of how to treat the entire set of
results arises. In order to avoid duplications, multiple regressions (differing only for one or more
control variables employed in the model) on the same set of observations, cannot be accounted
separately. One solution consists in reporting the average coefficient of the variable of interest.
While this choice implicitly includes all the results, it is not statistically orthodox. Since the
observation of our meta-analysis is the regression and not the paper, when multiple regressions
referred to the same set of observations, we retained only the most complete regression in terms of
control variables. On the contrary, analyses on different samples performed within the same study
were treated as fully replicated designs and therefore as independent observations.
Meta-analytic procedure
As detailed in the theoretical section, we focus on the effect of R&D investments and R&D capital,
as measures of technological assets, on firm market value. While several previous works have
14
shown a positive relationship between both variables and the firm’s market value, here we have two
distinct objectives. First, we intend to obtain an estimate of the true relationship between R&D
investments and R&D capital and firm market value, starting from the slopes reported in the studies
examined. Second, we aim at exploring to what extent the inclusion of several control variables
accounting for alternative hypotheses and other elements of the research design impact on the R&D
coefficient.
Meta-analysis usually focuses on the directionality and significance of the effects or on their
magnitude. In either case, a measure of association between the variables of interest from each of
the studies analyzed is needed. Bivariate correlation coefficients are normally used, while
procedures exist also for dichotomous comparisons relying on d-values. The use of regression
slopes and intercepts, on the contrary, is more controversial (Hunter and Schmidt, 1990: 202-206).
While the meaning of correlations is attenuated by the unreliability of the measures of both
independent and dependent variables, raw score regression slopes and intercepts are attenuated only
by measurement error in the independent variable. Moreover, regression slopes and intercepts are
usually not comparable across studies, unless all studies used exactly the same scales to measure
both variables. Finally, slopes and intercepts can be very difficult to interpret due to arbitrary
choices in the scaling of the variables.
All these limitations strongly suggest relying on correlations, even when examining studies
using regression models, collecting the relevant information from the correlation matrix that should
be normally reported. In our case, however, very few studies reported bivariate correlation
coefficients. The very stringent selection procedure used in the definition of the final sample,
however, offers the opportunity of overcoming all the abovementioned concerns on the use of
regression slopes. In fact, in all the studies selected both the dependent and the independent
variables are measured on identical scales. Therefore, the slope coefficient of interest (?) does not
15
suffer from scaling problems influencing its interpretability. It measures, in fact, the amount of
currency units by which the firm’s value increases or decreases as a consequence of an investment
of a currency unit in R&D activities relative. Moreover, in the functional forms selected, the
intercept has its own specific meaning in the estimation model (i.e. the amount of currency units by
which the firm’s value increases or decreases as a consequence of an investment of a currency unit
in any kind of assets). The coefficient ? can then be interpreted as a correlation coefficient and an
analysis of the effects of measurement errors in the dependent variable becomes meaningful again.
We then conducted all tests in accordance with the procedures presented and discussed by Hunter
and Schmidt (1990). Each slope needs to be weighted for the sample size, here measure for the
number of observations included in the regression model. The standard deviation of the observed
slopes can then be calculated to estimate the variability in the relationship observed.
Such variability, however, could be the sum of different components: true variation in the
population, variation due to sampling error, variation due to measurement error. Before proceeding
further in the analysis, assessing the impact on true variation of the effects of variables, it is
therefore important to eliminate the influence the random variation of the values reported by the
studies examined, and then systematic variation due to measurement problems.
We cumulated the results of the studies analyzed in five steps. These steps were common
across all different analyses performed, while the calculations changed according to the research
question of interest. Table 1 reports and describe the formula used for each calculation. First, we
computed the average uncorrected slope coefficient, as the average of all slope coefficient reported
by the studies examined weighted by the study’s sample size calculated as described above. Second,
we calculate the raw uncorrected variance of all the slope coefficients examined. Third, we
calculated for each study the attenuation factor to take into consideration the effect of measurement
errors in the dependent and independent variables. This third step was repeated four times,
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considering four levels of reliability: .7, .8, .9 and 1. Fourth, we calculate both the average sample
slope and the slope variance, corrected for artifacts’ influence. Before any analysis could be made,
however, one still has to eliminate from the variance calculated in the previous step the amount of
variance due to sampling error. The fifth and last step therefore consisted in the calculation of the
slope variance corrected for sampling error, resulting from the difference between the slope
variance corrected for artifacts’ influence and the sampling error variance, calculated on the average
sample slope corrected for artifacts’ influence.
We then tried to statistically assess the true relationship between R&D and firm market
value and the effect on this relationship of a set of variables through bivariate and multivariate
analyses. In the following section we describe these variables and why we chose them.
--- Insert Table 1 about here ---
Data coding
In coding our data we built a set of dichotomous variables accounting for two general aspects of the
research design: sample characteristics and control variables. This set of variables is described in
Table 2 for the studies using R&D investments and in Table 3 for the studies using R&D capital.
Both tables report information on the study, the sample characteristics and the estimation method
for each regression included in the meta-analysis along with a list of the variables used in the
following analyses.
--- Insert Table 2 about here ---
--- Insert Table 3 about here ---
With respect to sample characteristics, we defined two variables. With Country we
distinguish the between US and non-US studies, to account not only for the different dynamics of
17
the US stock market as compared to those of the other countries, but also for the fact that the studies
on the US are based on the Compustat Database, which can present higher levels of reliability
because of its methodological rigor (see Hall, 1990). Sample Size indicates whether the sample size
is higher or lower than the median value of all the regressions selected. This variable should control
for small sample or selection biases in the regression analyzed.
The other variables account for the presence of a set of controls in the regressions examined
that we theoretically expect to have a significant impact on the R&D coefficient. In analyzing the
papers we then proceeded in the following way. We first kept track of every single control variable
employed in the regression, and then we aggregated those variables measuring the same or very
similar constructs. While on one hand this choice might lead to a loss of specificity, on the other
hand it allowed us to identify the relevant variables at a higher level of aggregation. In addition,
from a methodological point of view, it increased the degrees of freedom in the following
estimation, which has a fundamental importance for meta-analyses with a limited number of
observations.
After this coding procedure, for the studies using R&D investments as proxy of
technological assets we identified the following variables:
Intangible assets. This variable is equal to 1 when in the regression analyzed there is a control
variable accounting for firm’s intangible assets other than R&D. It
encompasses two more detailed variables: Patent and legal protection and
Other intangibles. ‘Patent and legal protection’ includes the presence of the
following control variables in the regression: number of patents, patent stock,
patent citations, trademarks and industrial designs subjected to some form of
legal protection. ‘Other intangibles’ considers all intangible assets not included
in the previous variable, such as, for example, various measures of advertising
18
Firm Size: This variable indicates the presence in the regression of variables accounting for firm
size, measured either by Tangible assets or Total sales.6
Industry: This variable is equal to 1 when in a regression there is an industry-level control. It
encompasses two main factors: SIC-based industry dummies (SIC2, SIC3) and
Industry concentration (C4)
For the studies employing R&D Capital instead of R&D Investments we had to make some
little changes due to their somewhat different research designs. In particular, the variable Industry
accounts for the presence of Industry concentration (C4) and Technological cluster dummies,
cumulatively present in 4 regressions only, whereas none of the studies selected used industry
dummies as a control.
Statistical  tests
The slope variance corrected for sampling error calculated as explained above was used to compute
confidence intervals for the average sample slope corrected for artifacts’ influence. Confidence
intervals were then used to statistically test whether the relationship between a firm’s market value
and R&D investments was different from zero and to assess the univariate effect of a set of
variables on this relationship. The first set, aimed at analyzing the effect of different variables on
the R&D-market value relationship, includes the following fields: Patents and legal protection,
Other intangible assets, Industry, Firm Size. The second set includes both Country and Sample Size
                                                 
6 We also considered two other firm-level control variables: market share and leverage. However, we did not include
them in the analyses because they normally appeared in the same regressions where firm size was already controlled. As
a consequence, the variables built upon those variables were highly correlated with Size. Moreover, when included in
the estimation, they did not substantially change the results.
7 We also considered two other firm-level control variables: market share and leverage. However, we did not include
them in the analyses because they normally appeared in the same regressions where firm size was already controlled. As
a consequence, the variables built upon those variables were highly correlated with Size. Moreover, when included in
the estimation, they did not substantially change the results.
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control and is targeted to control for specific choices related to the research design made within the
different studies.
We also approach the ‘file drawer problem’ following the procedure recommended by
Rosenthal (1991: 103-109).  The purpose was to estimate the number of unretrieved studies
averaging null results that should exist if the results obtained from the retrieved studies were due to
chance alone.  Traditionally, meta-analyses consider unretrieved studies as those which have not
been published yet. The procedure, however, can logically be extended to consider the
generalizability of the results, which might as well be affected by the sampling criteria used. The
file-drawer test therefore becomes also a way to control for potential biases introduced by our
decisions to exclude some papers, as we explained above and to have not included other journals in
our analysis. Technically we needed to calculate the number of unobserved studies averaging null
results to bring the magnitude of the effect size observed to a negligible level. In our case, scaling
such value according to the metric shared by the variables considered in the analysis, we are
interested in computing the number of unobserved studies reporting null results necessary to bring
the value of the average corrected slope to less than 1. In this case, in fact, investing a currency unit
in R&D activities would destroy value. Given k the number of studies reviewed, ?µ the average
corrected slope, and ?c set equal to .8, we use the formula presented in Hunter and Schmidt (1990:
513) to compute x, the number of studies to be exceeded to invalidate the results of the meta-
analysis as follows:
x = k (?µ / ?c  – 1) [7]
Finally, we used multiple regression techniques to simultaneously assess the impact of all
the different variables of the coefficient ? assessing the relationship between R&D investment or
20
R&D capital and market value. It is important noticing that within these multivariate estimates, the
regression intercept represents the average slope coefficient, while each individual estimate
represents the increase or decrease in the average value of the coefficient ? due to the presence of
the specific factor in the study considered, after controlling for all other factors. The impact of each
single variable on the sample mean is tested by the significance level of the individual coefficient
estimates, while the effect of research design choices jointly including a set of predictors is tested
through the increment to R2 test. If the increase in the R2 is sufficiently large, we can conclude
that the predictors in question, when taken together, have an effect on the outcome variable. The
formula we employ to make this determination is the following:
?R2 ?df
(1? R2FullModel ) dfFullModel
 = F-test (?df, df full model) [8]
RESULTS
Tables 4 and 5 report the results of the meta-analysis of the relationship between R&D Investments
or R&D Capital and market value, as well as the changes in the coefficient of interest for different
levels of the variables considered. For the R&D Investment studies (Table 4), the overall results
indicate a strong support for a systematic positive relationship between the two variables. The
average corrected slope is equal to 3.12 and the 95% confidence interval varies between 1.29 and
4.94, indicating that the true population slope is always positive and well above zero. This result
confirms that in general stock market positively evaluate firms’ R&D investments.
--- Insert Table 4 about here ---
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A change in the reliability of the indicators used to estimate the relationship (i.e. Tobin’s Q
and the reported level of R&D Investments) has, as expected, an impact on both the average
corrected slope and the corrected slope variance. These changes are reflected in the 95% confidence
interval which varies between 1.36 and 7.21 at .9 level of reliability, between .02 and 12.23 at .8
and between -2.76 and 21 at .7, while the average corrected slope increases from 4.28 to 9.11.
Splitting our sample on the other variables, and considering a reliability level of .9 (Patents
and legal protection, Other intangible assets, Industry, Firm Size, Country and Sample Size), we
find that the average corrected slopes are quite constant over the split and that the 95% confidence
interval is always positive and well above zero. Table 4 reports also a comparison of the different
groups of observations based on the average corrected slope only. The differences in magnitude of
the coefficients are mostly not significant at conventional levels.
These observations are confirmed by the File Drawer Tests reported in the last column of
Table 4, indicating that the number of unretrieved studies reporting null or contrasting results,
needed to invalidate the conclusion that ? is positive, is large in comparison to the number of studies
actually reviewed, and  remains high for all the sample splits performed.
With respect to the studies using the R&D Capital (see Table 5), the average corrected slope
for the overall sample is .96. This is very close to the theoretical equilibrium value of 1, indicating
that in general stock markets consistently evaluate R&D expenditures. In other words, any currency
unit invested in R&D translates on average into about .96 currency units of stock market value. The
95% confidence interval ranges between -.31 and 2.24. This means that several study-specific
factors can moderate the value of the coefficient ?, posing greater interest on the analysis of the
variables identified in the previous section. As in the case of R&D Investments, changing the
reliability of the indicators modifies both the average corrected slope and the corrected slope
variance. The 95% confidence interval varies between -.14 and 2.78 at .9 level of reliability,
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between -.33 and 4.08 at.8 and between -1.03 and 6.64 at .7, while the average corrected slope
increases from 1.32 to 2.81.
--- Insert Table 5 about here ---
We then split the overall sample based on the described variables. While for those studies
that do not include Firm Size proxies the average corrected slope is equal to 1.63, the ACS
coefficient for studies including this variable is relatively smaller (.94). In this case the t-test is
statistically significant at the .1% level. Also the presence of Industry controls impacts on the
average corrected slope, which changes from 2.13 to 1.13, when studies do not include such
controls (the t-test is significant at the .1% level). Similar results are obtained when Patents are
considered, with the average corrected slope decreasing from 1.77 to 1.19 when studies do not
include such controls (the t-test is significant at the .1% level). Moreover, studies conducted on US
data report an average corrected slope smaller (1.27) than studies conducted on non-US data (1.99)
(the t-test is significant at the .1% level). Finally, while lower than in the case of R&D investments,
the values obtained for the File Drawer Test are generally high, compared to the number of studies
reviewed, if we exclude the case of studies including Other Intangibles.
As it can be seen from Tables 2 and 3, though, several of the research design and sample
characteristics univariately examined above are simultaneously present within the different studies.
Tables 6 and 7 therefore report the multivariate regression analyses for R&D Investment and R&D
Capital. For both groups of studies, we constructed a baseline model in which the dependent
variable (coefficient ?) is regressed on three main variables: Intangible assets, Industry and Firm
Size. Then we enriched the baseline model splitting the variable Intangibles into its more
disaggregated constituents: Patent and legal protection and Other intangibles. As a further step, in
order to control for specific effects associated with the sample characteristics, we added the sample
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related variables, Country and Sample Size, to the baseline and the enriched model. In the following
regressions, as explained in the previous section, the constant measures the average coefficient ? ,
whereas the other coefficients represent, ceteris paribus, the effect on ?  of different decisions
related to the research design of the studies investigated (control variables and sample
characteristics).
For all studies using R&D Investments (Table 6), the constant is always positive and
statistically significant, ranging from 3.48 to 3.59, thus indicating a general positive evaluation of
firms’ R&D investments by the stock markets and confirming the result already obtained from the
previous bivariate analyses. With respect to the moderating effects, in the baseline model (model 1)
the variable Intangible assets has a negative (-1.84) and significant coefficient (p-level<.01). This
means that when a regression accounts for intangible assets distinct from R&D investments, the
coefficient ? shrinks. Therefore, not accounting for other firm-level intangibles could lead to an
overestimation of the R&D market value as the value of other intangibles could be at least in part
attributed to R&D investments. The Industry variable has a positive (1.02) and significant
coefficient (p-level<.1), indicating that in the regressions controlling for industry-level effects the
estimate of coefficient ? is higher. This evidence suggests that when industry-level factors affecting
firm market value are accounted for, the R&D-market value relationship appears more clearly and
is more intense. Interestingly, the common firm-level control Size does not significantly affect the
R&D coefficient. When the variables Country and Sample size are introduced (model 2), the results
do not substantially change and the R2 does not significantly improve.
When the Intangibles are disaggregated (model 3), we note that both Patent and legal
protection and Other intangibles remain negative. However, only the former is statistically
significant (5% level). This indicates that when the studies account for other measures of
technological assets, such as patents, the market value of R&D investment results lower. It is then
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likely that stock markets evaluate a firm’s technological referring to multiple indicators, so that an
analysis based only on R&D-based measures could only partial reflect the value of a firm’s
innovation activities. Again when the variables Country and Sample size are introduced (model 4),
the results do not substantially change and the R2 does not significantly improve. The Patent and
legal protection coefficient is again positive, although it gets smaller and looses significance at
conventional levels. Considering the stability of the directionality of the effect, we interpret this
result as a consequence of the loss of degrees of freedom, the absence of any improvement in the
R2, and the limited number of observations available.
--- Insert Table 6 about here ---
Table 7 shows the results of the regressions on the studies based on R&D Capital. Similarly
to the results reported in Table 6, the constant is always positive and statistically significant, and
varies between 1.05 and 1.92, clearly indicating that each currency unit invested in R&D capital
generally enhances firm market value more than proportionally. Moreover, based on functions [2]
and [4] described above, it is evaluated by the stock markets more than an analogous investment in
tangible assets. This result would reject then the hypothesis of underestimation of R&D investments
by the stock markets advanced elsewhere.
The estimation of the baseline model (model 1) shows coefficients in line with those relative
to the previous group of studies. However, none of the coefficients of the variables is significant at
the conventional level. The introduction of the variables related to the sample characteristics has
interesting effects (model 2). First, the coefficient of Size becomes negative and statistically
significant (p-level <.1), indicating that controlling for firm size reduces the coefficient of R&D
capital. Positive effects on market value generally deriving form scale economies can be
erroneously attributed to the R&D capital if firm size is not controlled for. Second, both the
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variables Country and Large sample have a statistically significant coefficient. The negative sign of
the Country coefficient denotes a lower valuation of the R&D capital by the US stock market.
However, this result can not be correctly interpreted if the coefficient of Large sample is not taken
into consideration. In fact, most of the US samples are large, so that for several US-based studies
the net coefficient ? is the algebraic sum of the constant plus the coefficients of Country and Large
sample. The latter is positive, indicating that after controlling for all the other factors, the use of
smaller samples can lead to an underestimation of a firm’s R&D capital. This evidence has
important methodological implications because it suggests that reduced data availability is likely to
generate downward biased estimates of the coefficient ?. Third, the significant increase of R2 (? R2
test p-level <.1) indicates that in this case the two variables jointly increase the overall fit.
Disaggregating the Intangibles into its two components (model 3), we obtain significant
results for the variable Other intangibles, which has a negative (-.94) and statistically significant
(ten percent level) coefficient, whereas we do not have any significant coefficient for Patent and
legal protection. Differently from the previous group of studies, therefore, the relevant control
variable for the coefficient ? seems that relative to advertising expenditures and other intangible
assets.  However, while at least in part due to differences in the research designs of the studies in
the two groups, this result confirms that not controlling for neither technological assets nor other
intangibles can lead to overestimate the R&D market value. When adding Country and Sample Size
(model 4), we obtain again significant coefficients. Moreover, the Industry coefficient becomes
statistically significant at the 10% level, confirming the result already obtained for the group of
studies using R&D investments.
--- Insert Table 7 about here ---
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DISCUSSION AND CONCLUSIONS
The extent to which investments in innovation have a positive effect on firms’ market value has
attracted scholarly research and practitioners’ attention. With the increasing importance of financial
markets as a source of financing economic activities, the sensitiveness of investors to firms’
investments in innovation has become a critical area of attention for managers and stockholders.
This is indeed a critical question jeopardizing managers’ decisions on innovation management, such
as the amount of resources to allocate to R&D investments or equity-based R&D financing.
Empirical analyses have been conducted along the years, using different methodologies and
research designs. The relationship between firms’ market value and R&D investments has then
emerged as a growing research area, where economic, accounting and strategic management
perspectives have converged, using a variety of tools and approaches to assess the existence, the
directionality and the magnitude of such relationship.
However, two main questions, which made the interpretation of the results difficult to both
scholars and practitioners, emerge from a qualitative review of this literature. First, it is not clear
whether the investors evaluate the long-tem benefits of the investments in innovation. Several
authors have posed severe doubts on this point, suggesting that the returns on R&D investments are
systematically underestimated by the stock market (Lev and Sougiannis, 1996; Chan et al., 2001).
Second, a high degree of variability was found in the valuation of R&D investments in different
country and industry contexts (see Hall, 2000, for a review). Whether this finding depends on
different institutional factors or on different choices related to the research design is a question
without a clear answer.
In this paper we conducted a meta-analysis of the empirical literature linking R&D
investments and firm market value in order to shed some new light on these inconsistencies. We
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focused in particular on those studies that following the seminal contributions of Griliches (1981)
and Hirschey (1982) considered the firm as a bundle of assets and estimated the marginal effect of
R&D-based measures of innovation on firm market value. This stream of research is the first one to
have pursued empirical tests of the theoretical arguments developed and has attracted a growing
attention over the years, with a constant improvement of the research design and an attempt to
widen the geographical sources of the data outside the US market. Moreover, such approach is also
particularly interesting in the light of the debate on the notion of firm and of the sources of
competitive advantage, which has characterized in the last decade the strategic management
literature, and is heavily based on the role of intangible assets.
The objective of our meta-analysis was mainly twofold. First, we intended to assess if the
cumulated evidence from previous studies was supportive of a systematic positive evaluation of
firms’ R&D expenditures by the stock markets. Second, we aimed at assessing the magnitude of the
relationship between R&D investments and market value against a set variables related to the
research design. In this way, we tried to determine if different choices in terms of research design
significantly modified the results obtained by the previous studies.
The results presented in this paper move along these lines of enquiry, providing interesting
insights. First, they show that an overall analysis of the studies selected offer convergent and robust
evidence of a positive relationship between R&D investments and the market value of the firm.
More specifically, we can affirm not only that the true population slope is always positive and well
above zero, but also that the market values one currency unit invested in R&D activities as much
ore more than one currency unity invested in tangible assets.
The consistent valuation of R&D investments by the stock market is an important signal to
manager seeking to maximize shareholder wealth, as it suggests that a firm can invest in innovation
without fearing negative effects on the stock prices. Measurement errors in the dependent and
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independent variables, however, might introduce a significant bias both upward and, more
importantly in our case, downward, increasing the number of cases in which the market values one
dollar (or one Euro) invested in R&D activities less than one dollar (or one Euro) invested in any
other tangible assets.
When we account for the effect of variables in the bivariate and multivariate analyses, we
find some further intriguing results. First, when the studies control for the presence of other
intangible assets, such as patents and advertising, the market valuation of firms’ R&D investments
generally lowers. This evidence suggests that the investors on the stock market evaluate a firms’
innovation activities along different dimensions and referring to multiple indicators of the
innovation process, so that an analysis based only on R&D-based measures is at risk to be partial. In
this perspective, a more complete disclosure of the different dimensions of their innovation
activities could help traded firms to fill the well known R&D information gap with the external
investors (see Aboody and Lev, 2000) and have a more transparent and stable valuation on the stock
market.
Moreover, whereas adding industry-level controls seems to better specify the relationship
between R&D investment and market value, the firm-level variables widely adopted by the previous
studies, except measures of intangible assets, do not substantially affect the results. This indicates
that if the future work in this field intends to assess the effect of firm-specific characteristics on the
market value of innovation should move beyond the traditional control variables and try to define
original and innovative variables related to the management of innovation at the firm level. Clearly,
this effort will deal with the common trade-off between the depth of the study and the size and
generality of the sample. Finally, from a methodological point of view it is interesting to notice that
the sample size can matter in explaining the R&D market value. In particular, reduced availability
of data, which is typical of non-US countries, is at risk of downward biasing the results obtained.
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Our analysis suffers from some limitations, directly connected to some of the results
obtained. First of all, we have focused our attention only on one of the three research traditions
linking economic performance and R&D investments at the firm level and focusing on financial
markets. Future research should address the evidence available from the other research traditions
and find appropriate strategies to incorporate all possible models in the meta-analysis, possibly to
take a different angle on the questions analyzed in this paper or to answer to different questions.
Moreover, while we account for several important moderating factors, we leave out many other
factors such as the estimation technique used or the presence of interaction effects involving the
R&D coefficient because of the lack of a critical number of studies to perform these analyses. For
the same reason, we were also forced to aggregate the variables at a higher level, with a clear loss of
specificity. Additional efforts in extending the coding procedures of the studies and extending the
sample of studies analyzed will provide important information to further extend the meta-analysis.
Finally, since the studies not using a US sample were few, we could code the country variable only
as US and non-US. This choice did not allow us to have a clear result on the country effect,
although studies based on European data are increasingly being presented at conferences, with
results generally aligned with the ones obtained in the US, but also with some differences, usually
explained with the specific characteristics of the different stock markets (see Hall and Oriani, 2004).
The inclusion of new studies on non-US countries within the meta-analytic framework developed in
this paper will allow to more carefully evaluate this issue.
Despite all these limitations, the points raised in the paper are of interest to different
research communities and offer important indications on a topic whose relevance is directly
connected to the theory and practice of technology and innovation management. Considering the
evolution of several decision making tools emphasizing the role of opportunity increasing
investments to leverage on existing competencies for enhancing future competitive opportunities,
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the value attributed to such signals by the market can represent a critical opportunity to raise the
funds necessary to grow and commercially exploit the inventions developed. Value increasing or
destroying activities therefore cease to a be generic jargon to classify investment decisions and
becomes a powerful heuristic to be directly related to the expected evaluation expressed by
shareholders and investors also for highly intangible activities such as the ones related to the
development of innovation.
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Table 1 - Statistics used and computation methods
Statistic Computation Notes
Average observed slope (AOS) ??oini / ?ni (i = 1-s) ?oi = slope reported by study i
ni = sample size of study i
s = total number of studies examined
in the meta – analysis
Sampling error variance in
uncorrected slope (SEVUS)
( ) ( )sin
i
?=? ? 1     AOS1 22 Amount of variance among observed
slopes due to random error if no
correction for artifacts is applied
Uncorrected slope variance (USV) ( ) ( )sinn
ii
?=? ?? 1     AOSâ 2oi Total amount of variance among the
study not correcting for artifacts
influence
Attenuation factor (Ai) ai1 ai2 ai3 Total artifacts correction factor with:
ai1 = reliability of the independent
variable in study i
ai2 = reliability of the dependent
variable in study i
ai3 = attenuation factor for sample
size of study i calculated as 1 – (1/(2
ni – 1))
Average corrected slope (ACS) ( ) ( )sinn
ii
?=?? 1    AAâ 2iioi Average effect size obtained by meta
– analisys after correcting for all
artifacts influence
Sampling error variance in corrected
slope (SEVCS)
( ) ( )sinn
ii
?=?? 1    AASEVUS 2ii Amount of variance among corrected
slopes due to random error after
correction for artifacts is applied
Corrected slope variance (CSV) ( ) ( )sinACSn
ii
?=? ?? 1    AâA 2i2oi2i Total amount of variance among the
slopes after correcting for artifacts
influence
Sampling error corrected variance of
corrected slope (SECVCS)
CSV - SEVCS True variance among the slopes after
correcting for artifacts influence and
random variance
